SMIM
3.096,10
PKT
+13,82
PKT
+0,45
%
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.04.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 13.04.12 | EMS-CHEMIE buy | Sarasin Research | |
| 13.04.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.04.12 | Roche outperform | Cheuvreux SA | |
| 12.04.12 | Swatch (I) buy | Sarasin Research | |
| 11.04.12 | Roche neutral | Nomura | |
| 10.04.12 | Clariant hold | Deutsche Bank AG | |
| 05.04.12 | Roche outperform | Credit Suisse Group | |
| 04.04.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 03.04.12 | Clariant neutral | Nomura | |
| 03.04.12 | Julius Bär equal-weight | Morgan Stanley | |
| 02.04.12 | Barry Callebaut neutral | Sarasin Research | |
| 30.03.12 | Roche neutral | WestLB AG | |
| 30.03.12 | Roche outperform | Exane-BNP Paribas SA | |
| 30.03.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 29.03.12 | Roche overweight | J.P. Morgan Cazenove | |
| 28.03.12 | Helvetia Baloise neutral | J.P. Morgan Cazenove | |
| 27.03.12 | Helvetia Baloise buy | Sarasin Research | |
| 22.03.12 | Clariant sell | Goldman Sachs Group Inc. | |
| 22.03.12 | Avolta (ex Dufry) buy | ING | |
| 22.03.12 | Helvetia Baloise buy | Sarasin Research | |
| 22.03.12 | Straumann neutral | Sarasin Research | |
| 16.03.12 | ams-OSRAM kaufen | Erste Bank AG | |
| 16.03.12 | Roche outperform | Exane-BNP Paribas SA | |
| 15.03.12 | Avolta (ex Dufry) buy | UBS AG | |
| 14.03.12 | Avolta (ex Dufry) buy | Sarasin Research | |
| 14.03.12 | Avolta (ex Dufry) buy | ING | |
| 13.03.12 | Swatch (I) neutral | J.P. Morgan Cazenove | |
| 13.03.12 | Galenica neutral | Sarasin Research | |
| 13.03.12 | BELIMO neutral | UBS AG | |
| 08.03.12 | Tecan (N) neutral | Sarasin Research | |
| 08.03.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 02.03.12 | Swatch (I) buy | Sarasin Research | |
| 01.03.12 | Lindt neutral | Sarasin Research | |
| 01.03.12 | Adecco SA buy | Sarasin Research | |
| 01.03.12 | Adecco SA buy | ING | |
| 28.02.12 | PSP Swiss Property neutral | Sarasin Research | |
| 24.02.12 | Schindler neutral | UBS AG | |
| 23.02.12 | Roche overweight | J.P. Morgan Cazenove | |
| 22.02.12 | Straumann neutral | Sarasin Research |